Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-09-16

FDA Approved: LEVETIRACETAM — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a supplemental application for LEVETIRACETAM submitted by Amneal Pharmaceuticals LLC. The action confirms approval of the referenced supplement und…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)